How A Leadership Change At The FDA Could Impact Daily Lives

How a Shift in FDA Leadership Could Reshape Health, Safety, and Business Strategy By: [Your Name] | B2B Pulse When the Commissioner of the Food and Drug Administration (FDA) steps down—or gets replaced—most people don’t immediately think about their morning coffee, their child’s vaccinations, or the nicotine patch they’re using to quit smoking. But they … Read more

5 Benefits And Risks Of Using AI For Cybersecurity

AI for Cybersecurity: 5 Overlooked Benefits and Hidden Risks Every CISO Must Navigate You’ve heard the hype. AI is going to revolutionize cybersecurity. It’ll detect threats faster, automate responses, and eliminate human error. But here’s the cold, hard truth: the same tools that protect your organization can also be weaponized against you. After spending a … Read more

I skip the Hamptons and head to a coastal town in Connecticut instead. It’s less crowded and wonderful year-round.

From Traffic Jams to Coastal Calm: Why I Ditched the Hamptons for Madison, Connecticut As a revenue leader, you know the drill: long hours, high stakes, and the constant pressure to perform. When it’s time to unplug, the last thing you need is more gridlock. For years, I spent my weekends trading one traffic nightmare … Read more

OpenClaw’s creator used $1.3 million worth of AI tokens in a month and people are freaking out

The $1.3 Million Token Burn: What Peter Steinberger’s AI Spending Spree Means for B2B SaaS and GTM Strategies In the fast-moving world of AI and B2B SaaS, one number is turning heads and sparking debates: $1.3 million. That’s the monthly token bill Peter Steinberger, creator of the viral AI agent OpenClaw, posted to X on … Read more

The new competitive edge brand leaders need to know

Algorithmic Literacy: Why Your Brand’s Next Competitive Edge Isn’t Better Content—But Smarter Platform Strategy By: [Your Name], Chief Editor, B2B Pulse Let’s start with the conversation I dread having with any growth leader. It’s the one where they sit across from me, confident, armed with a library of whitepapers, polished case studies, and a calendar … Read more

Forbes x Unicycive Therapeutics

Scaling a Biotech Startup: The Unicycive Therapeutics Playbook for B2B Growth in Healthcare Introduction: When Science Meets Strategy In the high-stakes world of biotech, where clinical trials can make or break a company, scaling a business requires more than just breakthrough science. It demands a ruthless focus on go-to-market (GTM) execution, clear messaging, and operational … Read more